🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Bone Marrow Failure Syndromes

Investigation of the Genetics of Hematologic Diseases NCT02720679n/a1 site📍 Memphis St. Jude Children's Research Hospital CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia NCT03896269Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Liposome-encapsulated Daunorubicin-Cytarabine CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia NCT06633328EARLY Phase 11 site📍 Hanzhou Zhejiang University · Tests: CD7 CAR-T cells injection, Allogeneic hematopoietic stem cell transplantation TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children NCT04356469Phase 21 site📍 St. Petersburg Johns Hopkins All Children's Hospital · Tests: Haploidentical Hematopoietic Cell Transplantation Role of Acetaldehyde in the Development of Oral Cancer NCT05973656NA1 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: Alcohol, Biospecimen Collection, Breath Test Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency NCT06090669Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: TruSight Oncology, imatinib Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium NCT05343572EARLY Phase 11 site📍 Orange Hugh Taylor · Tests: Plerixafor Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site📍 Pittsburgh Paul Szabolcs · Tests: data collection A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia NCT07499284NA4 sites📍 Suzhou📍 Suzhou📍 Xuzhou The First Affiliated Hospital of Soochow University · Tests: Haploidentical hematopoietic cell transplantation combined with unrelated cord blood stem cells, Haploidentical hematop… Natural History of Acquired and Inherited Bone Marrow Failure Syndromes NCT05012111n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) NCT01351545n/a142 sites📍 Birmingham📍 Gilbert📍 Phoenix Center for International Blood and Marrow Transplant Resear… · Tests: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias NCT03653338Phase 1, Phase 21 site📍 Pittsburgh Paul Szabolcs · Tests: CD3/CD19 depleted leukocytes, CD45RA depleted leukocytes, Hydroxyurea, Rituximab, Alemtuzumab Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study NCT06650553NA1 site📍 Taiyuan Shanxi Bethune Hospital · Tests: Clinically diagnosed AA patients are divided into HLA-matched HSCT group and umbilical cord blood-supported haplo-HSCT … Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia NCT06695741Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Reduced dose of cyclophosphamide combined with standard immunosuppressive therapy Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms NCT06303193Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: pacritinib Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC NCT02356653EARLY Phase 11 site📍 Philadelphia Children's Hospital of Philadelphia · Tests: Transplant of stem cells with CD3+/CD19+ depletion (CliniMACs) Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study) NCT05196789n/a1 site📍 Melbourne Peter MacCallum Cancer Centre, Australia · Tests: whole genome and transcriptome sequencing Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders NCT03128996Phase 1, Phase 24 sites📍 New Haven📍 Wilmington📍 Grand Rapids Washington University School of Medicine · Tests: RIC regimen, GVHD prophylaxis regimen Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders NCT04644016Phase 21 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: Clofarabine, Fludarabine, Busulfan, Cyclosporine-A, Mycophenolate Mofetil Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform NCT06999954n/a1 site📍 Woburn Shwachman-Diamond Syndrome Alliance Inc Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia NCT07714512Phase 1, Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Isatuximab Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome NCT01624805Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, Methylprednisolone, Pegfilgrastim Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors NCT05194397Phase 23 sites📍 Duarte📍 Philadelphia📍 Memphis Children's Hospital of Philadelphia · Tests: Nicotinamide Riboside, Placebo, Exercise Intervention Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS) NCT07186179n/a1 site📍 New Hyde Park Northwell Health · Tests: Mobilization Regimen Clinical Study on Modified Allogeneic Hematopoietic Stem Cell Transplantation Regimen for Severe Aplastic Anemia NCT06378060Phase 21 site📍 Kunming Hematology department of the 920th hospital · Tests: Modified transplantation system A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA NCT07586735n/a1 site📍 Beijing Peking University People's Hospital · Tests: BFCA conditiong regimen CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases NCT06787560EARLY Phase 11 site📍 Hangzhou Zhejiang University · Tests: CD7 CAR-T cells injection, Allo-HSCT Familial Investigations of Childhood Cancer Predisposition NCT03050268n/a1 site📍 Memphis St. Jude Children's Research Hospital Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) NCT06648096Phase 1, Phase 22 sites📍 Hanover📍 Barcelona Fundació Institut de Recerca de l'Hospital de la Santa Creu… · Tests: Afatinib Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia NCT06517641Phase 225 sites📍 Birmingham📍 Duarte📍 Los Angeles Medical College of Wisconsin · Tests: Haploidentical donor bone marrow transplant, Unrelated donor bone marrow transplant
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy